NEW YORK (GenomeWeb News) – BGI and Portuguese startup Coimbra Genomics today announced a project to investigate the genetic basis of gastric cancer, the second most common cause of cancer after lung cancer.

The project is initially being funded with $900,000 and will involve researchers from the Institute of Molecular Pathology and Immunology at the University of Porto in Portugal, or IPATIMUP, a cancer research institute with "a particularly strong track record [in] gastric cancer," the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.